MYC and small cell lung carcinoma: These findings from the study of the GEMMs and the novel preSC-based model helped identify molecular subtypes of MYC family-driven SCLC, adding to the understanding of the oncogenic mechanisms and therapeutic vulnerabilities for each cancer subtype.